arrow_back Back to App

New Health Research Agency: Breakthroughs in Medicine

This act establishes a new agency within the National Institutes of Health to support innovative medical research. Its goal is to accelerate the development of new treatments and diagnostics, potentially improving access to advanced therapies and overall public health.
Key points
A new agency, ARPA-H, is created to fund high-risk, high-reward biomedical research projects that traditional institutions or companies might not pursue.
The agency will focus on overcoming scientific and technological barriers to rapidly introduce new solutions for preventing, diagnosing, and treating health conditions.
The agency's Director will have significant flexibility in hiring experts and managing projects, ensuring agility and speed of action.
Project funding will be available through grants, contracts, cash prizes, and flexible 'other transactions' to facilitate diverse collaborations.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_3819
Sponsor: Sen. Murray, Patty [D-WA]
Process start date: 2022-03-10
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

ARPA–H Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_3819.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2022-03-10.

What are the main provisions?

Key points include:

  • A new agency, ARPA-H, is created to fund high-risk, high-reward biomedical research projects that traditional institutions or companies might not pursue.
  • The agency will focus on overcoming scientific and technological barriers to rapidly introduce new solutions for preventing, diagnosing, and treating health conditions.
  • The agency's Director will have significant flexibility in hiring experts and managing projects, ensuring agility and speed of action.
  • Project funding will be available through grants, contracts, cash prizes, and flexible 'other transactions' to facilitate diverse collaborations.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Murray, Patty [D-WA].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health Public Investments